Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study

…, WP Maksymowych, J Maldonado-Cocco… - Annals of the …, 2016 - ard.bmj.com
Background Increased risk of some comorbidities has been reported in spondyloarthritis (SpA).
Recommendations for detection/management of some of these comorbidities have been …

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

…, X He, J Maldonado-Cocco… - The Journal of …, 2004 - pubmed.ncbi.nlm.nih.gov
… 1 , Taunton R Southwood, Prudence Manners, John Baum, David N Glass, Jose
Goldenberg, Xiaohu He, Jose Maldonado-Cocco, Javier Orozco-Alcala, Anne-Marie Prieur …

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional …

…, R Burgos-Vargas, J Maldonado-Cocco… - RMD open, 2021 - rmdopen.bmj.com
Objectives To characterise peripheral musculoskeletal involvement in patients with
spondyloarthritis (SpA) including psoriatic arthritis (PsA), across the world. Methods Cross-sectional …

[HTML][HTML] Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an …

…, R Perez-Alamino, JA Maldonado-Cocco… - Medicine, 2016 - journals.lww.com
… Landi, Margarita MD; Maldonado-Ficco, Hernán MD; Perez-Alamino, Rodolfo MD;
Maldonado-Cocco, José A. MD; Citera, Gustavo MD; Arturi, Pablo MD; Sampaio-Barros …

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a …

…, A Beaulieu, J MaldonadoCocco… - … : Official Journal of …, 2000 - Wiley Online Library
Objective This randomized, double‐blind study tested the hypothesis that rofecoxib, a drug
that specifically inhibits cyclooxygenase 2, would cause fewer gastroduodenal ulcers than …

Validation and crosscultural adaptation of an Argentine Spanish version of the Health Assessment Questionnaire disability index

…, MS Arriola, JA Maldonado-Cocco… - JCR: Journal of …, 2004 - journals.lww.com
Background: The Health Assessment Questionnaire (HAQ) is one of the most frequently
used instruments to assess functional capacity in activities of daily living. Objective: The …

Adherence to treatment in patients with ankylosing spondylitis

…, E Buschiazzo, C Ledesma, JA Maldonado Cocco… - Clinical …, 2013 - Springer
This study aims to determine the level of adherence to treatment in ankylosing spondylitis (AS)
patients and to identify possible factors associated to lack of adherence. We included …

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

A Deodhar, D van der Heijde, LS Gensler, TH Kim… - The Lancet, 2020 - thelancet.com
Background Ixekizumab, a high-affinity interleukin-17A (IL-17A) monoclonal antibody, has
previously shown efficacy in radiographic axial spondyloarthritis (also known as ankylosing …

[HTML][HTML] Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind …

A Deodhar, D Poddubnyy… - Arthritis & …, 2019 - Wiley Online Library
Objective To investigate the efficacy and safety of ixekizumab in patients with active radiographic
axial spondyloarthritis (SpA) and prior inadequate response to or intolerance of 1 or 2 …

Polyarteritis nodosa revisited

I Colmegna, JA Maldonado-Cocco - Current rheumatology reports, 2005 - Springer
… Nodosa Revisited • Colmegna and Maldonado-Cocco … Nodosa Revisited • Colmegna
and Maldonado-Cocco … Polyarteritis Nodosa Revisited • Colmegna and Maldonado-Cocco